Literature DB >> 22184422

The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor.

Graciela Rosen1, Michael N Sela, Gilad Bachrach.   

Abstract

Host defense peptides are innate immune effectors that possess both bactericidal activities and immunomodulatory functions. Deficiency in the human host defense peptide LL-37 has previously been correlated with severe periodontal disease. Treponema denticola is an oral anaerobic spirochete closely associated with the pathogenesis of periodontal disease. The T. denticola major surface protein (MSP), involved in adhesion and cytotoxicity, and the dentilisin serine protease are key virulence factors of this organism. In this study, we examined the interactions between LL-37 and T. denticola. The three T. denticola strains tested were susceptible to LL-37. Dentilisin was found to inactivate LL-37 by cleaving it at the Lys, Phe, Gln, and Val residues. However, dentilisin deletion did not increase the susceptibility of T. denticola to LL-37. Furthermore, dentilisin activity was found to be inhibited by human saliva. In contrast, a deficiency of the T. denticola MSP increased resistance to LL-37. The MSP-deficient mutant bound less fluorescently labeled LL-37 than the wild-type strain. MSP demonstrated specific, dose-dependent LL-37 binding. In conclusion, though capable of LL-37 inactivation, dentilisin does not protect T. denticola from LL-37. Rather, the rapid, MSP-mediated binding of LL-37 to the treponemal outer sheath precedes cleavage by dentilisin. Moreover, in vivo, saliva inhibits dentilisin, thus preventing LL-37 restriction and ensuring its bactericidal and immunoregulatory activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184422      PMCID: PMC3294656          DOI: 10.1128/IAI.05903-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  79 in total

Review 1.  Host defense peptides in the oral cavity.

Authors:  Deirdre A Devine; Celine Cosseau
Journal:  Adv Appl Microbiol       Date:  2008       Impact factor: 5.086

2.  Characterization of the Treponema denticola prtP gene encoding a prolyl-phenylalanine-specific protease (dentilisin).

Authors:  K Ishihara; T Miura; H K Kuramitsu; K Okuda
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Binding properties and adhesion-mediating regions of the major sheath protein of Treponema denticola ATCC 35405.

Authors:  Andrew M Edwards; Howard F Jenkinson; Martin J Woodward; David Dymock
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen.

Authors:  M Haapasalo; K H Müller; V J Uitto; W K Leung; B C McBride
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation.

Authors:  Sanhita Gupta; Santosh K Ghosh; Mary E Scott; Brian Bainbridge; Bin Jiang; Richard J Lamont; Thomas S McCormick; Aaron Weinberg
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

6.  The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes.

Authors:  D A Mathers; W K Leung; J C Fenno; Y Hong; B C McBride
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 7.  The role of gingipains in the pathogenesis of periodontal disease.

Authors:  Takahisa Imamura
Journal:  J Periodontol       Date:  2003-01       Impact factor: 6.993

8.  Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides.

Authors:  P L Mäkinen; K K Mäkinen; S A Syed
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37.

Authors:  Raquel F Epand; Guangshun Wang; Bob Berno; Richard M Epand
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

10.  M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus.

Authors:  Jason N Cole; Morgan A Pence; Maren von Köckritz-Blickwede; Andrew Hollands; Richard L Gallo; Mark J Walker; Victor Nizet
Journal:  MBio       Date:  2010-08-31       Impact factor: 7.867

View more
  7 in total

1.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

2.  LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations.

Authors:  Asaf Sol; Ofir Ginesin; Stella Chaushu; Laila Karra; Shunit Coppenhagen-Glazer; Isaac Ginsburg; Gilad Bachrach
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 3.  Roles of cathelicidins in inflammation and bone loss.

Authors:  Yuko Nakamichi; Kanji Horibe; Naoyuki Takahashi; Nobuyuki Udagawa
Journal:  Odontology       Date:  2014-07-22       Impact factor: 2.634

4.  Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease.

Authors:  Lior Doron; Shunit Coppenhagen-Glazer; Yara Ibrahim; Amir Eini; Ronit Naor; Graciela Rosen; Gilad Bachrach
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

Review 5.  Significance of LL-37 on Immunomodulation and Disease Outcome.

Authors:  Binbin Yang; David Good; Tamim Mosaiab; Wei Liu; Guoying Ni; Jasmine Kaur; Xiaosong Liu; Calvin Jessop; Lu Yang; Rushdi Fadhil; Zhengjun Yi; Ming Q Wei
Journal:  Biomed Res Int       Date:  2020-05-16       Impact factor: 3.411

Review 6.  The pathogenic mechanism of oral bacteria and treatment with inhibitors.

Authors:  Thuraya Elgreu; Sean Lee; Sabrina Wen; Radwa Elghadafi; Thanarut Tangkham; Yun Ma; Bing Liu; Serge Dibart; Xiaoren Tang
Journal:  Clin Exp Dent Res       Date:  2021-10-09

7.  Intracellular localization of Treponema denticola chymotrypsin-like proteinase in chronic periodontitis.

Authors:  Emilia Marttila; Anne Järvensivu; Timo Sorsa; Daniel Grenier; Malcolm Richardson; Kirsti Kari; Taina Tervahartiala; Riina Rautemaa
Journal:  J Oral Microbiol       Date:  2014-07-04       Impact factor: 5.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.